Whistle-blower Suit Over Pfizer's Lipitor Unsealed

Law360, New York (August 30, 2007, 12:00 AM EDT) -- The U.S. government has declined to intervene in a whistle-blower case brought by a former medical director at Pfizer Inc. who accused the drug giant of promoting off-label uses for its cholesterol-lowering medicine Lipitor, prompting a federal judge to order that the complaint be unsealed.

In a ruling handed down Thursday in the U.S. District Court for the Eastern District of New York, Judge Edward R. Korman ordered that Dr. Jesse Polansky's complaint be unsealed and served against Pfizer.

All other contents of the court's file...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.